The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 58 , ISSUE 2 ( April-June, 2016 ) > List of Articles

Original Article

Sino-Nasal Status in Patients with Chronic Obstructive Pulmonary Disease

S.K. Gupta, V.K. Jain, A.K. Singh, M. Mishra, T. Ojha

Keywords : COPD, Airway, Sino-nasal, Rhinitis, Spirometry, Nasal endoscopy, Mucociliary clearance, Sinuses

Citation Information : Gupta S, Jain V, Singh A, Mishra M, Ojha T. Sino-Nasal Status in Patients with Chronic Obstructive Pulmonary Disease. Indian J Chest Dis Allied Sci 2016; 58 (2):99-102.

DOI: 10.5005/ijcdas-58-2-99

License: CC BY-NC 4.0

Published Online: 17-11-2022

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with serious impact on quality of life (QoL). There are limited studies available supporting coexistence of sino-nasal involvement in COPD. Methods: A prospective study was conducted to evaluate sino-nasal status in patients with COPD (n=100) presenting to the Department of Respiratory Medicine, Mahatma Gandhi Medical College and Hospital, Jaipur from July 2011 to October 2012. COPD was diagnosed based on the Global initiative on Obstructive Lung Disease (GOLD) guidelines. Sino-nasal status was assessed by detailed history, radiograph of the para-nasal sinuses (PNS), nasal endoscopy and mucociliary clearance time. Results: Sino-nasal symptoms were present in 74 patients with COPD; nasal discharge (75.7%) being the most common. Tobacco smokers with COPD had a higher occurrence of sino-nasal symptoms (76.8%). Radiograph of para-nasal sinuses showed that maxillary sinus was most commonly involved. Nasal endoscopy revealed discharge in 63.5% cases. Nasal mucociliary clearance time was delayed (>11 to >40 min) in 98% cases. Nasal mucociliary clearance time was significantly delayed (>20 min) in COPD patients who were tobacco smokers as compared to non-smokers (53.7% versus 16.7%) and also related with increasing severity of COPD. Conclusions: Our observations suggest that sino-nasal involvement and delayed mucociliary clearance are common in patients with COPD, especially in tobacco smokers. Assessment of upper airway involvement in all the patients with COPD can help better therapeutic intervention and improvement in QoL.

PDF Share
  1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2014. www.goldcopd.org
  2. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006;6:29–36.
  3. Magnan A, Romanet S, Vervloet D. Rhinitis, nasal polyposis and asthma: clinical aspects. In: Wallaert B, Chanes P, Godard P, editors The Nose and Lung Disease: European Respiratory Monograph. Netherland: European Respiratory Society;2001:pp115–42.
  4. Nutku E, Toda M, Hamid QA. Rhinitis, nasal polyposis and asthma: pathological aspects. In: Wallaërt B, Chanes P, Godard P, editors The Nose and Lung Disease: European Respiratory Monograph. Netherland: European Respiratory Society; 2001:pp115–42.
  5. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983;128:833–8.
  6. Benninger MS. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinol 1999;13:435–8.
  7. Tran B, Kalhan R. The emerging role of systemic inflammation in chronic obstructive pulmonary disease. Clin Pulm Med 2008;15:55–62.
  8. Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systemic literature review. Chest 2013;144:1163–78.
  9. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013;1:73–83.
  10. Clini EM, Boschetto P, Lainscak M, Janssens W. Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. Bio Med Research (International Volume) 2014, Article ID 414928.
  11. Montnemery P, Svensson C, Adelroth E, Lofdahl CG, Andersson M, Greiff L, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596–603.
  12. Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TM, Donaldson GC, et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med 2003;97:909–14.
  13. Hurst JR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respir Med 2004;98:767–70.
  14. Nihlen U, Montnemery P, Andersson M, Persson CG, Nyberg P, Lofdahl CG, et al. Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD. Clin Physiol Funct Imaging 2008;28:240–50.
  15. Violetta MP, Wojciech JP, Zofia K, Jerzy M, Pawe3 G, Adam A. Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids. Int J COPD 2010;5:107–17.
  16. Alper K, Oznur A, Cesur G, Serdar B, Kursat E, Ibrahim A. The frequency of chronic rhinosinusitis/ nasal polyp in COPD and its effect on the severity of COPD. J Chronic Obst Pulmon Dis 2011; 8:8–12.
  17. Kumar A, Shah A. Occurrence of upper airway symptoms and their impact on quality of life (QoL) in patients with chronic obstructive pulmonary disease (COPD). Respirology 2008;13 (Suppl. 5):A109.
  18. Kumar N, Shekhar C, Kumar P, Kundu AS. Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr 2007;74:1131–2.
  19. Macnee W. Chronic bronchitis and emphysema. In: Seaton A, Seaton D, Leitch AG Textbook of Crofton and Douglas's Respiratory Diseases; 5th edition; Vol. 1. London: Blackwell Science Ltd; 2000:p.617.
  20. Lund VJ, Kennedy DW. Quantification for staging sinusitis. International Conference on Sinus Disease: Terminology, Staging, Therapy. Ann Otol Rhinol Laryngol 1995;104(Suppl.):17–21.
  21. Andersen I, Proctor DF. Measurement of nasal mucociliary clearance. Eur J Respir Dis 1983;127:37–40.
  22. Andersen I, Camner P, Jensen PL, Philipson K, Proctor DF. Nasal clearance in monozygotic twins. Am Rev Respir Dis 1974;110:301–5.
  23. Stanley P, MacWilliam L, Greenstone M. Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance. Br J Dis Chest 1984;78:62–5.
  24. Stanley PJ, Wilson R, Greenstone MA, MacWilliam L, Cole PJ. Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 1986;41:519–23.
  25. Devalia JL, Davies RJ. Human nasal and bronchial epithelial cells in culture: an overview of their characteristic and function. Allergy Proc 1991;12:71–9.
  26. Malik SK. Profile of chronic bronchitis in north India: The PGI experience (1972-1985). Lung India 1986;4:89–100.
  27. Jindal SK. A field study on follow up at 10 years of prevalence of COPD and peak expiratory flow rate. Indian J Med Res 1993;98:20–26.
  28. Ray D. A 5-years prospective epidemiological study of COPD in rural south India. Indian J Med Res 1995;101:238-44.
  29. Merkus FW, Verhoef JC, Schipper NG, Marttin E. Nasal muco ciliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev 1998;29:13–38.
  30. Wilson R, Alton E, Rutman A, Higgins P, Nakib AW, Geddes D, et al. Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 1987;70:272–9.
  31. Jang YJ, Myong NH, Park KH, Koo TW, Kim HG. Mucociliary transport and histologic characteristics of the mucosa of deviated nasal septum. Arch Otolaryngol Head Neck Surg 2002;128:421–4.
  32. Houtmeyers E, Gosselink R, Gayan RG, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999;13:1177–88.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.